Your browser doesn't support javascript.
loading
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.
Izumi, Kouji; Mizokami, Atsushi; Namiki, Mikio; Inoue, Shogo; Tanaka, Nobumichi; Yoshio, Yuko; Ishibashi, Kei; Kamiyama, Manabu; Kawai, Noriyasu; Enokida, Hideki; Shima, Takashi; Takahara, Shizuko.
Afiliación
  • Izumi K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan. azuizu2003@yahoo.co.jp.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Namiki M; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Inoue S; Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
  • Tanaka N; Department of Urology, Nara Medical University, Nara, Japan.
  • Yoshio Y; Nephro-Urologic Surgery and Andrology, Division of Reparative and Regenerative Medicine, Institute of Medical Life Science, Mie University Graduate School of Medicine, Tsu, Japan.
  • Ishibashi K; Department of Urology, Fukushima Medical University, Fukushima, Japan.
  • Kamiyama M; Department of Urology, University of Yamanashi, Chuo, Japan.
  • Kawai N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Shima T; Department of Urology, Toyama Prefectural Central Hospital, Toyama, Japan.
  • Takahara S; Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan.
BMC Cancer ; 17(1): 677, 2017 Oct 10.
Article en En | MEDLINE | ID: mdl-29017493
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata Resistentes a la Castración / Androstenos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata Resistentes a la Castración / Androstenos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón